European Archives - Page 91 of 1095 - European Medical Journal

FDA fast-tracks brelovitug for treatment of chronic hepatitis D

The drug has been granted Breakthrough Therapy designation by the FDA for the treatment of chronic hepatitis delta (CHD).

3D Printing Revolutionises Neurogenic Bladder Surgery

A recent study introduced a novel approach combining preoperative 3D printing with intraoperative ultrasound-guided puncture to address challenges in neurogenic bladder surgery.

Phase 2 Trial Results: TAK-071 Enhances Cognition in Parkinson’s Disease

TAK-071 enhances cognition in Parkinson’s disease but doesn’t reduce gait variability, phase 2 trial results reveal.

New Model Predicts Gastrointestinal Lesions in Eosinophilic Granulomatosis with Polyangiitis

A new study develops a model to predict gastrointestinal lesions in eosinophilic granulomatosis, highlighting eosinophils as a critical risk factor.

Cardiovascular Disease Increases Risk of Advanced Breast Cancer

Advanced breast cancer patients are likelier to have pre-existing cardiovascular disease, urging integrated screening strategies for early detection.

Longer Rescreening Intervals After Negative Colonoscopy for Low-Risk Individuals

A study suggests extending colonoscopy rescreening beyond 10 years for low-risk individuals, based on long-term colorectal cancer outcomes.

Increased ME/CFS Risk in Adults Post-COVID-19

The ongoing RECOVER-Adult study reveals that myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) develops significantly more frequently following SARS-CoV-2 infection.

Time-Restricted Eating with Exercise Reduces Fat Mass

A new meta-analysis has provided further insight into the effects of time-restricted eating combined with exercise on body composition.

How Comorbid Conditions Influence Alopecia Areata Progression

A comprehensive study of 2,657 patients assessed the relationship between chronic inflammatory disease comorbidities and alopecia areata characteristics.

Handshake on a green background

LEO Pharma to market Junshi Biosciences's toripalimab

Shanghai-based Junshi Biosciences has announced a partnership with Denmark’s LEO Pharma to distribute and commercialise the drug in Europe.